Concepedia

Natalie G. Marchevsky

NG

20

Publications

8K

Citations

15

H-Index

1975

Active since

Affiliations

University of Oxford(Current)

Jenner Institute

Centre for Human Genetics

Newcastle upon Tyne Hospitals NHS Foundation Trust

University of Southampton

Natalie G. Marchevsky is an author at University of Oxford specializing in veterinary science, medicine, and microbiology.

ORCID

Top concepts

Publications per year

1975–2022

20

Publications

20

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley et al. · The Lancet · 2021 · 649 citations · Full text

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

John Frater, Katie Ewer, Ane Ogbe et al. · The Lancet HIV · 2021 · 253 citations · Full text

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Amy Flaxman, Natalie G. Marchevsky, Daniel Jenkin et al. · The Lancet · 2021 · 253 citations · Full text

Rows per page

1–5 of 20